Powered by
-Eiger BioPharmaceuticals to Present at Biotech Showcase 2018

PALO ALTO, Calif. - Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of targeted therapies for orphan diseases, announced today that David Cory, President and CEO, will present a corporate update at Biotech Showcase 2018 on January 8th at 2:00 pm PT at the Hilton San Francisco (Franciscan - B Ballroom Level).

The corporate update will include a discussion of recent progress across all Eiger programs including Hepatitis Delta Virus (HDV), Pulmo

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox